Priority HOVON trials


Please find below the overview of the upcoming data analysis within HOVON trials. This list is meant for Local Data Managers to review which deadlines there are for certain trials. Of course we hope that it is possible to have  all data up to date and all queries answered within the general timelines as are specified in the eCRF instructions per trial. However in case there is some back log in providing data, this list below can be used to asses for which trial(s) we are most eager to receive your help in completing the data.

If the provided timelines below are not achievable for you, please contact the central data manager (listed at section Participating Parties at each trial) of the concerning trial.

Planned HOVON interim/final analyses for the coming 6 months

Updated: November 2023
(sorted by HOVON study number)

  • HO136 NHL: analysis primary endpoint (Q4-2023/Q1-2024)
  • HO150 AML: 1st efficacy interim analysis IDH1 cohort (Q4-2023)
  • HO150 AML: 2nd efficacy interim analysis IDH2 cohort (Q1-2024)
  • HO151 NHL: analysis primary endpoint (Q1 2024)
  • HO152 NHL: analysis primary endpoint (Q4-2023/Q1 2024)
  • HO158 CLL: final analysis induction (Q4-2023/Q1-2024)
  • HO159 CLL: 3rd interim analysis (Q4-2023/Q1-2024)